AHA News writes: At meetings this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data.
MedPAC Examines Medicare Quality Measurement, Drug Spending
More from United StatesMore posts in United States »
- HCCI 2020 Health Care Cost and Utilization Report
- Results From International Pilot Survey on Health Care Environmental Hygiene at Facility Level Highlights Need for Improvement
- AHRQ Release new HCUP Fast Stats
- Latest Hospice Data Refresh on Medicare Care Compare
- Parents of Hospitalized Children May Not Feel Equipped to Report Mistakes, According To Latest Leapfrog Group Patient Experience Report